Press release
Global Primary Immunodeficiency Diseases Market Expected to Reach US$7.5 bn by 2023 Boosted by Growth of New Therapies to Treat PIDD
PIDD is a group of rare diseases that are genetic in nature. The commonality among PIDDs is that a section of the immune system is either non-functional or missing. General symptoms of PIDD include extremely low resistance to serious infections or illnesses. This also includes damage to organs as well as life-threatening cases where a body’s immune system starts attacking cells and tissues generated in the body itself. The most common method of treating PIDDs is through the use of human plasma. There are extreme cases of PIDD where a patient will need complete stem cell replacement.The report explains the global PIDD market using four criteria for categorization: disease, test, treatment, and geography.
On the basis of disease, the global PIDD market is divided into the segments of innate immune disorders, cellular immunodeficiency, and antibody deficiency. Each of these can be further divided into multiple sub-segments consisting of specific diseases and syndromes. The report states that the segment of antibody deficiency diseases topped the global PIDD market in 2014. It is also expected to be the fastest-growing segment of the market in the given forecast period, owing to the high prevalence of antibody deficiency diseases. On average, about 60% to 70% of PIDD cases registered have been from this segment.
Avail a Free Sample Research Report: http://bit.ly/1XiX1yG
The most common, and therefore the most medically significant, antibody deficiency disease is common variable immune deficiency. CVID affects about one in 25,000.
On the basis of test, the global PIDD market is segmented into blood testing and prenatal testing. Of these, the market was led by prenatal tests in 2014 in terms of revenue, owing to the expensive nature of the tests. Prenatal tests are also the first type of test that parents opt for while diagnosing their offspring for PIDD.
In the event that parents find out that the fetus is expected to suffer from PIDDs, they are given the option to discontinue the pregnancy. At the same time, parents who have shown signs of passing on autosomal recessive diseases are also given the option of artificial insemination.
On the basis of treatment, the global PIDD market is divided into immunoglobulin replacement therapy, stem cell and gene therapy, antibiotic therapy, and others. The report expects immunoglobulin replacement therapies to be the fastest-growing segment of the global PIDD market for the given forecast period.
On the basis of geography, the global PIDD market was dominated by North America in 2014, owing to a high rate of diagnosis, the presence of advanced medical care, and the high level of research and development efforts being taken by the top players in this region. In comparison, Asia Pacific and Rest of the World are expected to show a slow rate of growth in the global PIDD market, due to low awareness rates.
The key players in the global PIDD market are Grifols S.A., Octapharma AG, LFB S.A., Kedrion S.p.A., Bio Products Laboratory Ltd., CSL Behring LLC, Biotest AG, and Baxter International, Inc.
Browse Full Research Report: http://bit.ly/1PbYyX0
About Us
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.
Contact Us
Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Primary Immunodeficiency Diseases Market Expected to Reach US$7.5 bn by 2023 Boosted by Growth of New Therapies to Treat PIDD here
News-ID: 343280 • Views: …
More Releases from Transparency Market Research
RF Chip Inductor Market Size to Reach over USD 1.8 billion by 2031 - Transparenc …
RF Chip Inductor Market are essential components in various electronic devices, providing inductance and functioning as filters, oscillators, and transformers. They play a crucial role in ensuring the efficiency and performance of RF circuits. With the rapid advancement in telecommunications, consumer electronics, and automotive industries, the demand for RF chip inductors has seen a significant rise. These components are integral in applications such as smartphones, IoT devices, and automotive electronics,…
Solid Tires Market Expected to Witness Impressive Growth at a 8.1% CAGR by 2031
The latest research study released by Transparency Market Research on "Solid Tires Market Forecast to 2023-2031 ″ research provides accurate economic, global, and country-level predictions and analyses.
Solid Tires market is estimated to attain a valuation of US$ 760.0 Mn by the end of 2031, states a study by Transparency Market Research (TMR). Besides, the report notes that the market is prognosticated to expand at a CAGR of 8.1% during…
Automotive Cyber security Market Sales Estimated to Hit USD 10.5 Billion by 2031 …
The latest research study released by Transparency Market Research on "𝐀𝐮𝐭𝐨𝐦𝐨𝐭𝐢𝐯𝐞 𝐂𝐲𝐛𝐞𝐫 𝐬𝐞𝐜𝐮𝐫𝐢𝐭𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐅𝐨𝐫𝐞𝐜𝐚𝐬𝐭 𝐭𝐨 𝟐𝟎𝟐𝟑-𝟐𝟎𝟑𝟏 ″ research provides accurate economic, global, and country-level predictions and analyses. It provides a comprehensive perspective of the competitive market as well as an in-depth supply chain analysis to assist businesses in identifying major changes in industry practices. The market report also examines the current state of the Automotive Cyber security industry, as…
Ready-mix Concrete Market to Witness Exponential Growth with a CAGR of 6.1% from …
The latest research study released by Transparency Market Research on "𝐑𝐞𝐚𝐝𝐲-𝐦𝐢𝐱 𝐂𝐨𝐧𝐜𝐫𝐞𝐭𝐞 𝐌𝐚𝐫𝐤𝐞𝐭 𝐅𝐨𝐫𝐞𝐜𝐚𝐬𝐭 𝐭𝐨 𝟐𝟎𝟐𝟑-𝟐𝟎𝟑𝟏 ″ research provides accurate economic, global, and country-level predictions and analyses. It provides a comprehensive perspective of the competitive market as well as an in-depth supply chain analysis to assist businesses in identifying major changes in industry practices. The market report also examines the current state of the Ready-mix Concrete industry, as well as…
More Releases for PIDD
Primary Immunodeficiency Diseases Market Forecast To 2023 Explored In Latest Res …
Primary Immunodeficiency Diseases Market: Key Insights
In response to the rising incidence of antibody diseases, Transparency Market Research (TMR) forecasts the global primary immunodeficiency market to surge at 6.1% CAGR between 2015 and 2023. Developed regions such as Europe and North America are predominantly contributing to the growth witnessed by this market. The consistent approval of novel therapeutic options for primary immunodeficiency diseases (PIDD) and extensive research and development investments by…
Primary Immunodeficiency Diseases Market Research Report: Forecast up to 2023
Primary Immunodeficiency Diseases Market: Key Insights
In response to the rising incidence of antibody diseases, Transparency Market Research (TMR) forecasts the global primary immunodeficiency market to surge at 6.1% CAGR between 2015 and 2023. Developed regions such as Europe and North America are predominantly contributing to the growth witnessed by this market. The consistent approval of novel therapeutic options for primary immunodeficiency diseases (PIDD) and extensive research and development investments by…
Demand for Primary Immunodeficiency Disease Therapies to Increase as Governments …
With only a handful of companies enjoying the major share of the revenue pie, the global primary immunodeficiency diseases (PIDD) market exhibits a consolidated vendor landscape. As per Transparency Market Research (TMR), CSL Behring LLC and Grifols S.A. emerged dominant in the market with a share of 60.5% in 2014. Baxter International, Inc. and Octapharma AG are other prominent enterprises operating in the global PIDD market.
These companies have been…
Primary Immunodeficiency Diseases Market Research Report : : Key Trends and Fore …
Primary Immunodeficiency Diseases Market: Key Players
Some of the most prominent companies in the global primary immunodeficiency diseases market are CSL Behring LLC, Baxter International, Inc., Grifols S.A., Octapharma AG, and others.
Primary Immunodeficiency Diseases Market: Key Insights
In response to the rising incidence of antibody diseases, Transparency Market Research (TMR) forecasts the global primary immunodeficiency market to surge at 6.1% CAGR between 2015 and 2023. Developed regions such as Europe and North…
Primary Immunodeficiency Diseases Market Research Report by Regional Analysis : …
Primary Immunodeficiency Diseases Market: Key Insights
TMR expects the global PIDD market to reach US$7.5 bn by the end of 2023, from a valuation of US$4.3 bn in 2014.
In response to the rising incidence of antibody diseases, Transparency Market Research (TMR) forecasts the global primary immunodeficiency market to surge at 6.1% CAGR between 2015 and 2023. Developed regions such as Europe and North America are predominantly contributing to the growth witnessed…
Primary Immunodeficiency Diseases Market is Expected to Rise at a Remarkable CAG …
With only a handful of companies enjoying the major share of the revenue pie, the global primary immunodeficiency diseases (PIDD) market exhibits a consolidated vendor landscape. As per Transparency Market Research (TMR), CSL Behring LLC and Grifols S.A. emerged dominant in the market with a share of 60.5% in 2014. Baxter International, Inc. and Octapharma AG are other prominent enterprises operating in the global PIDD market.
These companies have been…
